XHR:NYSEXenia Hotels & Resorts, Inc. Analysis
Data as of 2026-09-11 - not real-time
$17.64
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Xenia Hotels & Resorts, Inc. is priced at $17.64, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 12.2%. RSI sits at 28.3, which reads as oversold, and MACD momentum is bearish. Price has been bracketed by support at $17.45 and resistance at $19.82.
Valuation screens as undervalued: a P/E of 27.8 sits below the sector average of 30.9. The average analyst target implies 19.6% above today's level. Revenue is growing at 2.8% on a -0.7% profit margin. The 3.18% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 23.4%, a beta of 0.55 and a maximum drawdown of 19.3%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Valuation screens as undervalued: a P/E of 27.8 sits below the sector average of 30.9. The average analyst target implies 19.6% above today's level. Revenue is growing at 2.8% on a -0.7% profit margin. The 3.18% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 23.4%, a beta of 0.55 and a maximum drawdown of 19.3%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
Xenia Hotels & Resorts Inc XHR reports robust Q2 2026 results with 5.Updated Jul 30, 2026 0 Orlando, Fla., July 30, 2026 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. NYSE: XHR "Xenia" or...Orlando, Fla., July 30, 2026 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. NYSE: XHR "Xenia" or the "Company" today...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- RSI at 28.3 signals oversold conditions
- Trading above the 200-day average of 16.84
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- RSI at 28.3 signals oversold conditions
- P/E of 27.8 versus sector average of 30.9
- Trading above the 200-day average of 16.84
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 27.8 versus sector average of 30.9
- Negative profit margin of -0.7%
- Analyst targets imply +19.6% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth2.80%
Profit Margin-0.66%
P/E Ratio27.8
ROE-0.63%
ROA2.50%
Debt/Equity118.28
P/B Ratio1.5
Op. Cash Flow$181.9M
Free Cash Flow$72.6M
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI28.3
Support$17.45
Resistance$19.82
MA 20$18.77
MA 50$19.74
MA 200$16.84
MACDBearish
VolumeIncreasing
Fear & Greed Index93.14
Valuation
Target Price$21.10
Upside/Downside19.61%
GradeUndervalued
TypeValue
Dividend Yield3.18%
Risk Assessment
Beta0.55
Volatility23.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.